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Abstract Winter flounder contains two distinct anti-freeze
protein isoforms, which are the liver-type extracellular anti-
freeze proteins and the skin-type intracellular anti-freeze protein.
The skin-type anti-freeze proteins exhibit lower anti-freeze
activities than the liver-type isoforms and this might be due to
their lacking complete ice-binding motifs. One of the skin-type
anti-freeze proteins, skin-type anti-freeze protein-3, does contain
putative overlapping ice-binding motifs with the sequences
‘-K9DT-’ and ‘-DT^K-’. Synthetic anti-freezes containing 0^3
repeats of the ‘-DT^K-’ motif were tested for stability and
activity. Loss of the single ‘-DT^K-’ of skin-type anti-freeze
protein-3 increases the anti-freeze activity and increasing the
number of motifs to two or three lowers the activity. The
decrease in activity with an increasing frequency of the motif
correlates with a decrease in the helical content of these peptides
at 0‡C.
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1. Introduction
The winter £ounder Pleuronectus americanus contains the
type I, alanine-rich, K-helical anti-freeze polypeptides (AFPs)
to protect them from freezing in icy seawaters [1]. Recent
studies from our laboratories have shown that the ¢sh con-
tains two distinct AFP isoforms that are encoded from di¡er-
ent subsets of genes, namely the liver-type extracellular AFPs
(w£AFPs) and the skin-type intracellular AFPs (wfsAFPs) [2].
Although these AFPs are structurally similar, the wfsAFPs,
however, exhibit a much lower anti-freeze activity as com-
pared to the liver-type isoforms. The presence of two distinct
AFP isoforms in the same ¢sh species with a di¡erent cellular
localization and biosynthetic pathways implied that there may
be di¡erences between these proteins in conferring freezing
protection, their structural/functional relationships as well as
the transcriptional mechanisms controlling their tissue-speci¢c
expressions [3].
The structure of the most abundant w£AFP (w£AFP-6,
previously known as HPLC-6) has been extensively studied
which included X-ray crystallography [4], NMR [5] and pep-
tide synthesis [6,7]. It is a single rigid amphipathic helix with a
regular 11 amino acid repeat of ThrX2Asn/AspX7, where X is
mainly alanine. The distance of the Thr repeats in this AFP
(16.5 Aî ) closely matches the ice lattice [8]. Based on the 1.5 Aî
X-ray crystal structure, Sicheri and Yang postulated the pres-
ence of ice-binding motifs (IBMs) which act as anchors or
contact surfaces to strengthen the a⁄nity of its ice-binding
[4]. Because of the occurrence of IBMs with the sequence
‘-LT^N-’ in w£AFP-6, putative IBMs were suggested to occur
in other type I AFPs. These consisted of the sequences
‘-K9DT-’ and ‘-KT^D-’ [4]. In comparison with the w£AFPs,
the skin AFPs are generally de¢cient in IBMs and this might
account for the lower anti-freeze activity of the skin AFPs [2].
Based on the w£AFP-6 IBM and the putative ones sug-
gested in other AFP sequences, two overlapping putative
IBMs can be identi¢ed in a skin-type AFP, wfsAFP-3. One
motif, ‘-K9DT-’, corresponds precisely to one of those postu-
lated previously in other AFPs [4]. However, it has been
shown to have no role in the activity of wfsAFP [9]. The other
compositionally equivalent motif ‘-DT^K-’ remained to be
tested. We have therefore investigated the role of this motif
in wfsAFP-3 by measuring the stability and activity of syn-
thetic peptides containing 0^3 repeats of this motif.
2. Materials and methods
2.1. Reagents and chemicals
Fmoc amino acid derivatives and Fmoc-Arg(Mtr)-Nava Syn KA
100 resin were purchased from Calbiochem-Novabiochem Group
(San Diego, CA, USA).
Reagents used in peptide synthesis were purchased separately as
stated. N,N-dimethylformamide (DMF) (ACS grade, BDH Canada,
Etobicoke, Ont., Canada), tri£uoroacetic acid (TFA, Chem-Impex
International, Wood Dale, IL, USA), thioanisole, m-cresol, 1,2-etha-
nedithiol, ethylmethylsul¢de, diisopropylethylamine and bromotri-
methylsilane (Aldrich Chemicals, Milwaukee, WI, USA), o-(7-aza-
benzotriazol-1-y1)-l,l,3,3-tetramethyluronium hexa£uorophosphate
(HATU, Perspective Biosystems, Burlington, Ont., Canada) and pi-
peridine (ACS grade, Anachemia Canada, Mississauga, Ont., Cana-
da).
2.2. Peptide synthesis
Peptides were synthesized at the Hospital for Sick Children Bio-
technology Service Centre, Toronto, on the Pharmacia-LKB-Biolynx
4170 Automated Peptide Synthesizer (Pharmacia Biotech, Montreal,
Que., Canada) using the continuous £ow Fmoc chemistry on the
NovaSyn KA 100 resin [10]. A solution of 20% piperidine in DMF
was used for the removal of the Fmoc protection group. For each
gram resin (0.1 nmol substitution), a four times excess of Fmoc amino
acid activated with HATU and diisopropylethylamine (1:1:2, mol/
mol/mol) [11] was used for the coupling reaction. The reaction time
was 1 h.
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After the synthesis, the side chain-protected peptide-resin conju-
gates were acetylated separately using acetic anhydride/diisopropyl-
ethylamine (2:1) at room temperature for 1 h. The acetylated pep-
tide-resin conjugates were washed with DMF, diethyl ether and dried
under reduced pressure. The dry peptide-resin conjugates were cleaved
with 20 ml TFA containing 4 ml thioanisole, 0.4 ml m-cresol, 2 ml 1,2-
ethanedithiol, 3 ml ethylmethylsul¢de and 4 ml bromotrimethylsilane
at 0‡C for 1 h. The peptides were extracted, dissolved in 0.1% TFA
and desalted on a Sephadex G10 column.
The homogenity of the peptides was analyzed by reverse phase
HPLC on a Waters WBondapak C18 column, amino acid analysis
and by atmospheric pressure ionization mass spectrometry.
2.3. Measurement of anti-freeze activity
Anti-freeze activity was measured as thermal hysteresis (di¡erence
between the melting and freezing temperatures) essentially following
the procedure of Chakrabartty et al. [6]. Proteins were dissolved in
0.1 M NH4HCO3. Activity measurements were performed on a series
of dilutions using a Clifton Nanolitre Osmometer (Clifton Technical
Physics, Hartford, NY, USA). For each dilution, measurements were
made from three wells and the average was taken.
2.4. Measurement of circular dichroism (CD) spectra
CD spectra were measured using a Jasco J-600 spectropolarimeter.
A water-jacketed (0.1 cm) quartz cell was used. The concentrations of
peptides for CD measurement were between 0.1^0.2 mg/ml in 0.1 M
NH4HCO3, pH 8.5. The mean residue ellipticity at a given wave-
length, [a]V, was expressed in degree cm2 dmol31. The fraction helix
was calculated as described by Green¢eld and Fasman [12] employing
222 nm instead of 208 nm:




The ellipticity [a]coil222 of each peptide in 6.0 M guanidine hydrochlo-
ride at 25‡C was assumed to represent 0% helix formation and the
ellipticity [a]helix222 for 100% helix formation was calculated from Yang
et al. [13]: [a]n = [a]r(13k/n), where n is the chain length and k is a
wavelength-dependent factor (at 222 nm, k = 2.5 and [a]r = 37 400
degree cm2 dmol31).
3. Results
3.1. Peptide design and synthesis
In order to test the role of the putative IBM ‘-DT^K-’ in
ice-binding in the wfsAFPs, a series of synthetic peptides
based on the structure of wfsAFP-3 were synthesized (Table
1). One peptide (1IBM) was synthesized with the sequence of
wfsAFP-3 and it contained a single complete IBM. In other
peptide analogues, residues corresponding to the Asp and Lys
of the complete IBM were substituted for Ala at speci¢c res-
idues in order to create new IBMs (Fig. 1). Thus, two peptides
(2IBM and 3IBM) which contain two or three of this IBMs
were synthesized. A peptide containing only incomplete IBM
(0IBM) was synthesized by placing an Ala at the positions
corresponding to the D and K of the IBM in the 1IBM pep-
tide. These peptides were N-terminal acetylated to mimic their
native analogue. All the synthetic peptides were puri¢ed by
reverse phase HPLC and con¢rmed by amino acid analysis
and mass spectrometry.
3.2. Anti-freeze activities
Fig. 2 shows the anti-freeze activities of the synthetic pep-
tides as thermal hysteresis in a concentration-dependent man-
ner. The 0IBM peptide, which lacks any complete IBM, has a
slightly higher activity than the 1IBM peptide, suggesting that
loss of this IBM has no e¡ect on anti-freeze activity. Peptide
Table 1
Amino acid sequences of the synthetic AFPs
1 11 22 33
0IBM MDAPAKAAAA TAAAAKAAAEA TAAAAAKAAAA TKAAAAR
1IBM MDAPAKAAAA TAAAAKAAAEA TAAAAAKAAAD TKAKAAR
2IBM MDAPAKAAAA TAAAAKAAAED TAAKAAKAAAD TKAKAAR
3IBM MDAPAKAAAD TAAKAKAAAED TAAKAAKAAAD TKAKAAR
The peptides were nominated based on the number of putative IBMs. 1IBM has the same sequence as wfsAFP-3 and contains one IBM ‘-DT^
K-’, the other three peptides contain zero, two and three IBMs, respectively. The amino acid residues involved in the IBMs are underlined.
Fig. 1. Helical net representation of the w£AFP-6, wfsAFP-3 and
its synthetic analogues. The presumptive complete IBMs are circled.
Residues that interact or are predicted to interact in order to stabi-
lize ice-binding conformations are joined. The incomplete IBMs,
Thr residues are also circled.
Fig. 2. The concentration-dependence of anti-freeze activities of the
synthetic AFPs. Anti-freeze activities (thermal hysteresis) of solu-
tions containing a series of AFP concentrations were measured as
described under Section 2. The symbols representing di¡erent AFP
analogues are indicated in the ¢gure.
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analogues containing two and three IBMs were slightly less
active than the 1IBM peptide.
3.3. CD spectra
The secondary structures of these synthetic peptides were
determined by CD spectroscopy (Fig. 3). All these peptides
showed typical double-minimum spectra of K-helices at 0‡C.
The calculated helical contents for 0IBM, 1IBM, 2IBM and
3IBM peptides at 0‡C were 75.2, 78.5, 70.0 and 65.9%, respec-
tively, indicating that introduction of more than one such
IBM results in destabilization of the helical structure.
4. Discussion
Anti-freeze proteins have been postulated to retard ice crys-
tal growth by an adsorption-inhibition process [14] in which a
set of hydrophilic groups on the AFPs match to the oxygen
atoms via hydrogen bonds on a particular plane of the ice
lattice. Knight et al. [8] have hypothesized that some hydro-
gen-binding groups on the AFPs might become incorporated
into the ice lattice so that they can each form three hydrogen
bonds. More recently, X-ray crystallographic studies of
w£AFP-6 [4] showed that the Thr side chains are sterically
constrained (M1 =361 þ 4‡) by the backbone helical structure
and the side chains of Asp-5, Asn-16 and Asn-27 (Fig. 1)
adopt a similar conformation (M1 =375 þ 3‡, M2 = 13 þ 13‡).
Two leucine side chains (Leu-12 and Leu-23) stabilize the
asparagine conformation through close Van der Waals inter-
action. This led to the postulation of IBMs in which the
composed residues are rigidly constrained to form an excep-
tionally £at ice-binding surface. In this model, the threonine
hydroxyls do not protrude su⁄ciently into the ice lattice and
become tetrahedrally linked and a less stringent hydrogen-
binding criterion was proposed. The IBM hypothesis has
been challenged by an NMR study [5] which showed that
the proposed ice-binding side chains (threonines and aspara-
gines) are not constrained but rather adopt many possible
rotameric states in solution. However, this does not rule out
the possibility that these side chains form a stable IBM upon
binding to ice.
Our studies clearly showed that ‘-DT^K-’ in wfsAFP-3 is
not a ‘functional IBM’. Moreover, the existence of more than
one of this ‘putative IBM’ actually resulted in lowering of the
anti-freeze activity and destabilization of helix. Thus it is im-
plied that the IBM hypothesis based on the structure of
w£AFP-6 may be restricted and may not be extended to other
type I AFPs. A recent ice-binding model for a shorthorn
sculpin AFP based on ice crystal etching and molecular dy-
namics simulation [15] did not support the existence of IBM
‘-KT^D-’ as postulated by Sicheri and Yang [4]. Similarly, a
four repeat AFP (AFP-9) isolated from £ounder serum
showed an enhanced anti-freeze activity compared to the
four repeat yellow tail £ounder AFP [16], yet it lacks any
complete IBM as postulated by Sicheri and Yang [4].
The lower helical contents of peptide analogues containing
two and three IBMs are likely due to the replacement of Ala
with Lys and Asp which have lower helix propensities [17].
These may also correlate with the lower anti-freeze activities.
This is consistent with our recent ¢nding that the lower activ-
ities of some expressed mutants of wfsAFP-2 correlated with
their lower helical content [9]. Although the relationship be-
tween helix stability and anti-freeze activity has not been
studied systematically, there is evidence that indicates that
helix stability does a¡ect anti-freeze activity. Chakrabartty
and Hew [7] introduced two additional salt bridges into
w£AFP-6 and created a peptide analogue with an enhanced
K-helicity. This highly helical analogue was able to a¡ect the
ice crystal growth rates at 7^8-fold lower concentrations than
the native AFP. Another study [18] showed that introducing
an internal lactam bridge reinforced the K-helicity of a mini-
mized AFP analogue and thus conferred the anti-freeze activ-
ity.
This study clearly rules out the role of ‘-DT^K-’ in
wfsAFP-3 as a functional IBM. It also provides further evi-
dence that helix stability a¡ects anti-freeze activity.
Acknowledgements: We thank Linda Mark for the preparation of the
manuscript. This work was ¢nancially supported by the Medical Re-
search Council of Canada (to C.L.H.). K.V. Ewart was a recipient of
a MRC Fellowship and Q.L. is a recipient of a U of T Open Fellow-
ship, University of Toronto and a Research Training Fellowship,
Hospital for Sick Children. We thank Dr V.S. Ananthanarayanan
for helpful discussion and the use of the CD spectrometer.
References
[1] Davies, P.L. and Hew, C.L. (1990) FASEB J. 4, 2460^2468.
[2] Gong, Z., Ewart, K.V., Hu, Z., Fletcher, G.L. and Hew, C.L.
(1996) J. Biol. Chem. 271, 4106^4112.
[3] Chan, S.L., Miao, M., Fletcher, G.L. and Hew, C.L. (1997) Eur.
J. Biochem. 247, 44^51.
[4] Sicheri, F. and Yang, D.S.C. (1995) Nature 375, 427^431.
[5] Gronwald, W., Chao, H., Reddy, D.V., Davies, P.L., Sykes, B.D.
and So«nnichsen, F.D. (1996) Biochemistry 35, 16698^16704.
[6] Chakrabartty, A., Yang, D.S.C. and Hew, C.L. (1989) J. Biol.
Chem. 264, 11313^11316.
[7] Chakrabartty, A. and Hew, C.L. (1991) Eur. J. Biochem. 202,
1057^1063.
[8] Knight, C.A., Cheng, C.C. and DeVries, A.L. (1991) Biophys. J.
59, 409^418.
[9] Lin, Q., Ewart, K.V., Yan, Q., Wong, W.K.R., Yang, D.S.C. and
Hew, C.L. (1999) (submitted).
[10] Sheppard, R.C. (1983) Chem. Br. 19, 402^414.
Fig. 3. CD spectra of synthetic AFPs. The CD spectra of the syn-
thetic peptides were measured at 0‡C using a Jasco J-600 spectropo-
larimeter, as described under Section 2. The four spectra from bot-
tom to top are 1IBM, 0IBM, 2IBM and 3IBM, respectively.
FEBS 22206 18-6-99
Q. Lin et al./FEBS Letters 453 (1999) 331^334 333
[11] Carpino, L.A., El-Faham, A. and Albericio, F. (1994) Tetrahe-
dron Lett. 35, 2279^2282.
[12] Green¢eld, N. and Fasman, G.D. (1969) Biochemistry 8, 4108^
4116.
[13] Yang, J.T., Wu, C.S. and Martinez, H.M. (1986) Methods Enzy-
mol. 130, 208^269.
[14] Raymond, J.A. and DeVries, A.L. (1977) Proc. Natl. Acad. Sci.
USA 74, 2589^2593.
[15] Wierzbicki, A., Taylor, M.S., Knight, C.A., Madura, J.D., Har-
rington, J.P. and Sikes, C.S. (1996) Biophys. J. 71, 8^18.
[16] Chao, H., Hodges, R.S., Kay, C.M., Gauthier, S.Y. and Davies,
P.L. (1996) Protein Sci. 5, 1150^1156.
[17] Chakrabartty, A. and Baldwin, R.L. (1995) Adv. Protein Chem.
46, 141^176.
[18] Houston Jr., M.E., Chao, H., Hodges, R.S., Sykes, B.D., Kay,
C.M., So«nnichsen, F.D., Loewen, M.C. and Davies, P.L. (1998)
J. Biol. Chem. 273, 11714^11718.
FEBS 22206 18-6-99
Q. Lin et al./FEBS Letters 453 (1999) 331^334334
